Thumbnail Article_Sydnexis EU approval (2)
June 6, 2025

European Approval for Sydnexis’ Pediatric Myopia Treatment

Sydnexis’ SYD-101 low-dose atropine formulation is now the first pharmaceutical option in Europe for myopia. The European Commission has granted…

shutterstock_2115637928_800
July 14, 2023

DOT Lenses: Our new ally in the fight against childhood myopia?

One of the recent developments in myopia control for children is SightGlass Vision’s Diffusion Optics Technology (DOT) — a joint…

Discover our fascinating content at issuu

explore